Health and Human Services Secretary Tom Price’s description of medication-assisted treatment for addiction as “substituting one opioid for another” is inaccurate, according to addiction experts who have asked Price to “set the record straight.”
The practice of mindfulness may be helpful for people trying to reduce their dose of the opioid medication buprenorphine/naloxone (Suboxone), according to Zev Schuman-Olivier, MD, Executive Director, Center for Mindfulness and Compassion, Cambridge Health Alliance.
Aetna is the latest health insurer to announce it will no longer require preauthorization for opioid addiction treatment, Kaiser Health News reports. The change takes effect this month and applies to commercial plans.
All patients on long-term opioid treatment should be co-prescribed the opioid overdose antidote naloxone, even if they are not considered to be at high risk of an opioid overdose, according to the director of the University of New Mexico Pain Center.
A new injectable treatment for opioid addiction showed promise in a late-stage study, according to The Wall Street Journal. The study involved weekly and monthly injections of buprenorphine for the treatment of moderate to severe opioid use disorder.